Document Server@UHasselt >
Research publications >
Please use this identifier to cite or link to this item:
|Title: ||Screening for Atrial Fibrillation (AF) in Belgium: a multicentre trial.|
|Authors: ||CLAES, Neree|
Mairesse, Georges H.
|Issue Date: ||2011|
|Citation: ||European Journal of Cardiovascular Prevention and Rehabilitation, 18 (April). p. S30-S30|
|Abstract: ||Screening for Atrial Fibrillation (AF) in Belgium: a multicentre trial
Claes Neree, Goethals Marnix, Goethals Peter, Mairesse Georges, Schwagten Bruno,
Nuyens Dieter, Schrooten Ward, Vijgen Johan
Atrial fibrillation (AF) is the most common arrhythmia in clinical practice. The estimated prevalence is 0.4-1% in the general population, increasing with age to 8% in those older than 80y - . Epidemiological data of this arrhythmia in Belgium are scarce. It is important to screen for AF because patients with AF have a 5 times more risk for an ischemic stroke . The CHA2DS2-VASscore calculates the risk for stroke in those patients, a score ≥2 necessitate a therapy with anticoagulants .
Patients above 40 years were invited through different channels (TV, radio, journals, website, posters, leaflets) for a free screening in 69 hospitals allocated over Belgium during one week. After filling in a question on their personal history of AF, they had to fill in a questionnaire about their CHAD2-score. Afterwards a one channel ECG was taken using a versatile Heart Scan Device (Omron HCG-801-E©) by a trained nurse or a physician. If the ECG was positive for AF the patient was referred to their physician for follow-up. An Access database was constructed to collect the data and statistics were done in SPSS.
11.550 patients were screened. 38% are male and 62% are female with a mean age of 59y (+/-SD 11). 860 patients declared a history of AF (7.4%), 10.188 had no history of AF and in 502 the history was missing. 229 (1.9%) of the total population had AF on the one lead ECG where 148 were newly detected. According the CHADS2 68 patients had a score of 0, 70 of 1 and 91 of ≥2. For the CHA2DS2-VASscore the distribution was as follows: 14 patients with 0, 46 with 1 and 169 with ≥2.
Screening campaigns are feasible and able to detect 2% of patients with AF. A significant proportion of these patients are at risk for trombo-embolic event.|
|Type: ||Journal Contribution|
|Appears in Collections: ||Research publications|
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.